Sort
21,453 grants matching “tuberculosis”
IeDEA Asia-Pacific Research Collaboration
$2,522,324Annette H Sohn · Foundation For Aids Research · U01 · FY2025 · AI
Emory- Duke- Orlando- CDC (EmDOC) Clinical Trials Unit
$2,518,885Jeffrey Lennox · Emory University · UM1 · FY2014 · AI
BUILDING GLOBAL CAPACITY FOR DIAGNOSTIC TESTING OF TUBERCULOSIS, MALARIA AND HIV
$2,515,037Heidi Albert · Foundation/Innovative New Diagnostics · U2G · FY2011 · PS
TUBERCULOSIS ELIMINATION AND LABORATORY
$2,514,031Michelle Conner · Georgia State Dept Of Human Resources · U52 · FY2008 · PS
Excess cardiovascular inflammation in TB and HIV: EXFIN-TB
$2,513,201Gregory P. Bisson · University Of Pennsylvania · R01 · FY2025 · HL
Metabolic factors that control the spectrum of human tuberculosis
$2,504,101David Branch Moody · Brigham And Women'S Hospital · U19 · FY2021 · AI
Integrated system for Category C infectious disease diagnostics in resource-limi
$2,500,809Darrell P Chandler · Harvard Medical School · U19 · FY2015 · AI
AIDS Clinical Trials Group for Research on Therapeutics for HIV and Related Infections
$2,500,001Judith S. Currier · University Of California Los Angeles · UM1 · FY2023 · AI
International Epidemiologic Databases to Evaluate AIDS - Southern Africa (IeDEA-SA)
$2,500,000Matthias Egger · Universitat Bern · U01 · FY2016 · AI
COLLABORATIVE AIDS PROGRAMME OF RESEARCH IN SOUTH AFRICA
$2,500,000Salim S Abdool Karim · University Of Kwazulu-Natal · U19 · FY2006 · AI
Novel weapon evolution in mycobacterial pathogenesis, dispersal and ecological persistence
$2,499,999Mark E Benbow · Michigan State University · · FY2019 · BIO
Adjuvant Development in the context of a vaccine to protect against tuberculosis
$2,494,333Vaxine Pty Ltd · N01 · FY2018 · AI
Pathway Analysis in Tuberculosis
$2,492,917Sabine Ehrt · Weill Medical Coll Of Cornell Univ · P01 · FY2021 · AI
Wits HIV Research Group CLINICAL TRIAL UNIT (CTU) reapplication
$2,492,623Ian Matthias Sanne · Wits Health Consortium (Pty), Ltd · UM1 · FY2023 · AI
Development of Vaccines to Prevent Tuberculosis
$2,490,549Robert A Seder · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI
Translational Approaches for Pathogens of Human Significance
$2,490,273Jennifer F Friedman · Rhode Island Hospital · P20 · FY2025 · GM
HPMI: Host Pathogen Mapping Initiative
$2,489,172Nevan J Krogan · University Of California, San Francisco · U19 · FY2023 · AI
Caribbean, Central and South America network for HIV epidemiology (CCASnet)
$2,488,424Catherine C McGowan · Vanderbilt University · U01 · FY2013 · AI
Vanderbilt HIV Clinical Trials Unit
$2,487,433David W Haas · Vanderbilt University Medical Center · UM1 · FY2020 · AI
Pathway Analysis in Tuberculosis
$2,480,141Sabine Ehrt · Weill Medical Coll Of Cornell Univ · P01 · FY2022 · AI
Discovery of natural product-based drugs from bacterial symbionts of insects
$2,479,629Cameron Robert Currie · University Of Wisconsin-Madison · RC4 · FY2010 · GM
Rapid Tests for Drug Resistance to Detect Extensively Drug-Resistant Tuberculosis
$2,478,524Antonino None Catanzaro · University Of California, San Diego · U01 · FY2009 · AI
CENTERS FOR DISEASE CONTROL AND PREVENTION, TUBERCULOSIS ELIMINATION, LABORATORY
$2,476,791L Masae Kawamura · San Francisco Department Of Public Health · U52 · FY2011 · PS
HPMI: Host Pathogen Mapping Initiative
$2,475,950Nevan J Krogan · University Of California, San Francisco · U19 · FY2024 · AI
Development of Therapeutic Candidates for Biodefense, Antimicrobial Resistant (AMR) Infections and Emerging Infectious Diseases
$2,475,623Nader Fotouhi · Global Alliance For Tb Drug Development · N01 · FY2024 · AI